SCHEMBL20040005

SCHEMBL20040005

CCOC(=O)Cc1nc(C)nc(Cl)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 3/20 0.41
RECQL P46063 1/20 0.40
HSD17B10 Q99714 2/20 0.39
RAB9A P51151 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MAPK1 P28482 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5844147 0.81 MAPK1 (0.46) ALDH1A1HSD17B10RAB9ACA12CA1
SCHEMBL27284948 0.77 MAPK1 (0.50) SMN1; SMN2ALDH1A1HSD17B10RAB9ACYP1A2
SCHEMBL2743309 0.72 ALDH1A1 (0.43) ALDH1A1HSD17B10CYP1A2KMT2AKDM4E
SCHEMBL4538724 0.71 MAPT (0.43) SMN1; SMN2ALDH1A1RECQLRAB9ACA12
SCHEMBL8880069 0.71 DPP4 (0.44) SMN1; SMN2ALDH1A1HSD17B10RAB9ACYP1A2
SCHEMBL27289016 0.71 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HSD17B10RAB9ACYP1A2
SCHEMBL1748473 0.70 MAPK1 (0.46) ALDH1A1HSD17B10RAB9ACA12CA1
SCHEMBL15155090 0.70 ADORA3 (0.49) SMN1; SMN2ALDH1A1RAB9ACA12CA1
SCHEMBL7374513 0.70 MAPK1 (0.47) SMN1; SMN2ALDH1A1HSD17B10RAB9ACA12
SCHEMBL10004608 0.69 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1HSD17B10RAB9ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3091012-B1 CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF CENTREXION THERAPEUTICS CORP (US) 2018-04-11 EP disclosed